TSPO Imaging Using the Novel PET Ligand [18f]ge-180: Quantification Approaches in Patients With Multiple Sclerosis

EJNMMI Research - Germany
doi 10.1186/s13550-017-0340-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Initial Evaluation of 11c-Dpa-713, a Novel TSPO PET Ligand, in Humans

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

PET Imaging of PARP Expression Using [18F]olaparib

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

In Vivo Assessment of Neuroinflammation in Progressive Multiple Sclerosis: A Proof of Concept Study With [18F]DPA714 PET

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2018English

Molecular Imaging of Prostate Cancer With 18f-Fluorodeoxyglucose PET

Nature Reviews Urology
Urology
2009English

18f-Fecnt: Validation as PET Dopamine Transporter Ligand in Parkinsonism

Experimental Neurology
Developmental NeuroscienceNeurology
2010English

11c-Choline vs. 18f-FDG PET/CT in Assessing Bone Involvement in Patients With Multiple Myeloma

World Journal of Surgical Oncology
SurgeryOncology
2007English

First 18f-Labeled Ligand for PET Imaging of uPAR: In Vivo Studies in Human Prostate Cancer Xenografts

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2013English

Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI

Frontiers in Physiology
Physiology
2019English

Mortality in Patients With Multiple Sclerosis

Neurology
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy